Frontlight ResearchEarly access
Not yet recruitingPhase 4
BETARGET : Randomized trial of individualizing BETA-lactam taRGET combining therapeutic drug monitoring, minimal inhibitory concentration and model-based dose adjustment, in Intensive Care Units patients with gram negative bacilli infection
Key facts
- Who runs it
- Centre Hospitalier Universitaire De Rennes
- Where
- France19 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 672 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 1 Feb 2029
- Type of study
- Interventional
- Record updated
- 6 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age ≥ 18 years
- Hospitalization in ICU
- Sepsis
- Enterobacterales or non-fermenting Gram negative bacilli microbiological documentation
- Beta-lactam antibiotic therapy with CEFOTAXIME, CEFTAZIDIME, CEFEPIME, PIPERACILLINE, PIPERACILLINE-TAZOBACTAM, MEROPENEME, AMOXICILLINE, CEFTAZIDIME-AVIBACTAM
- Information of the patient or a relative/legal representative, or use of the emergency procedure
Who cannot take part
- Allergy to beta-lactams
- Urinary infection
- Plurimicrobial infection
- “Complex” infection: central nervous system infection, bone or joint infection
- Protected person (adults legally protected (under judicial protection, guardianship or supervision), person deprived of their liberty, pregnant woman, lactating woman and minor)
- Impossibility to measure the MIC of the defined bacteria
- Absence of coverage by a social security scheme
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Evaluate the impact of an individualized strategy (BETARGET strategy including MIC, TDM and model-based adjustement) for beta-lactam therapy in ICU NGB-infected patients on the ICU free days at day 28.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 6 August 2026